Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

Schmitz-Winnenthal FH, Hohmann N, Niethammer AG. et al
Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: a randomized, placebo-controlled, phase 1 trial.

OncoImmunology 2015;
4 (04) e1001217

Bibliographische Angaben herunterladen

Aufrufen in: